IntelliPharmaCeutics International Inc. is engaged in the research development and commercialization of controlled-release and targeted pharmaceutical products.


Updates from The Motley Fool

Latest updates on Intellipharmaceutics International from Fool.com.

There is no available coverage of Intellipharmaceutics International at this time.



Stock Performance

View Interactive IPCI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Intellipharmaceutics International.
Current Price: $2.22
Prev Close: $2.27
Open: $2.25
Bid: $2.18
Ask: $2.37
Day's Range: $2.19 - $2.35
52wk Range: $1.41 - $3.35
Volume: 79,300
Avg Vol 466,712
Market Cap: $67M
P/E (ttm): -5.97
EPS (ttm): ($0.38)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Intellipharmaceutics International.
CAPS Rating 1 out of 5
 
17 Outperform
5 Underperform
CAPS All Stars
 
1 Outperform
3 Underperform

How do you think Intellipharmaceutics International will perform against the market?



You pick for Intellipharmaceutics International is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Isa Odidi, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Intellipharmaceutics International.

IntelliPharmaCeutics International Inc. is engaged in the research development and commercialization of controlled-release and targeted pharmaceutical products.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers